Wikidata

(Q64184696)

English

Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis

clinical trial

In more languages

Statements

title
Effect of Ocrelizumab on Gray Matter Pathology, Leptomeningeal Inflammation and Cognitive Dysfunction in Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
start time
2 April 2019
0 references
end time
April 2021
0 references
number of participants
30
0 references
minimum age
18 year
0 references
maximum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64184696&oldid=1857600527"